Cutting edge: the etiology of autoimmune thyroid diseases - PubMed (original) (raw)

Review

Cutting edge: the etiology of autoimmune thyroid diseases

Deirdre Cocks Eschler et al. Clin Rev Allergy Immunol. 2011 Oct.

Abstract

Significant progress has been made in our understanding of the mechanisms leading to autoimmune thyroid diseases (AITD). For the first time, we are beginning to unravel these mechanisms at the molecular level. AITD, including Graves' disease (GD) and Hashimoto's thyroiditis (HT), are common autoimmune diseases affecting the thyroid. They have a complex etiology that involves genetic and environmental influences. Seven genes have been shown to contribute to the etiology of AITD. The first AITD gene discovered, HLA-DR3, is associated with both GD and HT. More recently, this association was dissected at the molecular level when it was shown that substitution of the neutral amino acids Ala or Gln with arginine at position beta 74 in the HLA-DR peptide binding pocket is the specific sequence change causing AITD. Non-MHC genes that confer susceptibility to AITD can be classified into two groups: (1) immune-regulatory genes (e.g., CD40, CTLA-4, and PTPN22); (2) thyroid-specific genes-thyroglobulin and TSH receptor genes. These genes interact with environmental factors, such as infection, likely through epigenetic mechanisms to trigger disease. In this review, we summarize the latest findings on disease susceptibility and modulation by environmental factors.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Huber A, Menconi F, Corathers S, Jacobson EM, Tomer Y. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev. 2008;29:697–725. - PMC - PubMed
    1. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997;84:223–243. - PubMed
    1. Weetman AP. In: Chronic autoimmune thyroiditis, in Werner and Ingbar’s The thyroid. Braverman LE, Utiger RD, editors. Lippincott Williams and Wilkins; Philadelphia, PA: 2000. pp. 721–732.
    1. Menconi F, Oppenheim YL, Tomer Y. In: Graves’ disease, in Diagnostic criteria in autoimmune diseases. Shoenfeld Y, Cervera R, Gershwin ME, editors. Humana Press; Totowa, N.J: 2008. pp. 231–235.
    1. Gebe JA, Swanson E, Kwok WW. HLA class II peptide-binding and autoimmunity. Tissue Antigens. 2002 Feb;59:78–87. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources